Rituximab-induced interstitial pneumonitis : report of two cases and literature review

We report two cases of rituximab (RTX)-induced interstitial pneumonia in two lymphoma patients receiving RTX treatment. Interstitial pneumonia was successfully managed in these two cases after a one-week-long intervention with corresponding treatments without affecting further treatment of the primary disease. RTX-induced interstitial pneumonia is characterized by a latent onset with an unclear pathological mechanism and absence of typical symptoms. High-resolution CT scan can provide valuable evidence for early diagnosis of RTX-induced interstitial pneumonia, which might be attributed partially to an increased susceptibility to P. jirovecii and fungal infection due to prolonged RTX treatment.

Medienart:

Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

Nan fang yi ke da xue xue bao = Journal of Southern Medical University - 35(2015), 1 vom: 23. Jan., Seite 129-32

Sprache:

Chinesisch

Beteiligte Personen:

Ping, Bao-Hong [VerfasserIn]
Yue, Chun-Yan [VerfasserIn]
Zhu, Yang-Min [VerfasserIn]
Gao, Ya [VerfasserIn]
Wu, Bin [VerfasserIn]
Hong, Jia-Qiong [VerfasserIn]

Themen:

4F4X42SYQ6
Antibodies, Monoclonal, Murine-Derived
Case Reports
Journal Article
Review
Rituximab

Anmerkungen:

Date Completed 16.09.2015

Date Revised 02.12.2018

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM245581723